2017 |
United States – 47 states and District of Columbia |
5,629 (as of Dec. 31, 2017) |
Data not yet available |
[12] |
2016-Feb 1, 2017 |
United States – Arkansas |
2,706 |
66% 2 dose, 7% 1 dose |
[17] |
2015–2016 |
United States – Illinois |
317 |
16% 3 dose, 73% 2 dose, 4% 1 dose |
[18] |
2014 |
United States |
1,151 |
Varies across outbreak locations |
[12, 52] |
2012–2013 |
Belgium |
4,061 |
69% 2 dose, 30% 1 dose |
[19] |
2009–2011 |
Jerusalem |
3,130 |
46.9% 2 doses, 28.3% 1 dose |
[20] |
2013 |
United Kingdom |
28 |
84% 2 doses, 8% 1 dose |
[21] |
2013 |
Poland |
2,436 |
10.3% 2 doses, 43.2% 1 dose |
[22] |
2009 |
United States – New York |
1,521 |
75% 2 doses, 13% 1 dose |
[23, 24] |
2006 |
Austria |
214 |
10.7% 2 doses, 30.2% 1 dose |
[25] |
2006 |
United States |
6,584 |
62.5% 2 doses, 24.8% 1 dose |
[26] |
2005–2006 |
Czech Republic |
5,998 |
70.6% 2 doses, 1.1% 1 dose |
[27] |